Treatment of recurrent head and neck cancer: Re-irradiation or chemotherapy?

Clinical Oncology

Volumn 17, Issue 3, 2005, Pages 138-147

  Creak, A L ^a   Harrington, K ^a   Nutting, Chris ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; Chemoradiotherapy; Chemotherapy; Head and neck cancer; Re irradiation; Recurrent tumour; Surgery; Toxicity; Trial

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOTOXIC AGENT; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; METHOTREXATE; MITOMYCIN; PACLITAXEL;

ARTICLE; BEAM THERAPY; BONE NECROSIS; BRACHYTHERAPY; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CRANIAL NEUROPATHY; DIAGNOSTIC ERROR; DRUG DOSE REGIMEN; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NASOPHARYNX CANCER; NONHUMAN; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RADIOSENSITIVITY; SOFT TISSUE INJURY; TREATMENT FAILURE; UNITED KINGDOM;

ANTINEOPLASTIC AGENTS; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; RADIOTHERAPY; SALVAGE THERAPY;

EID: 16344381018     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.10.008     Document Type: Article

References (63)

1. C. Kotwall K. Sako M.S. Razack U. Rao V. Bakamjian D.P. Shedd Metastatic patterns in squamous cell cancer of the head and neck Am J Surg 154 1987 439-442
2. W. Nishijima S. Takooda N. Tokita S. Takayama M. Sakura Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy Arch Otolaryngol Head Neck Surg 119 1993 65-68
3. D.P. Slaughter H.W. Southwick W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963-968
4. I.C.M. Paterson G. John D. Adams Jones Effects of deprivation on survival of patients with head and neck cancer: A study of 20,131 cases Clin Oncol 14 2002 455-458
5. R. Williams Recurrent head and neck cancer: The results of treatment Br J Surg 61 1974 691-697
6. J. Ridge Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence Semin Oncol 20 1993 419-429
7. S.R. Mabanta W.M. Mendenhall S.P. Stringer N.J. Cassisi Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes Head Neck 21 1999 591-594
8. A.A. Forastiere B. Metch D.E. Schuller et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study J Clin Oncol 10 1992 1245-1251
9. A.A. Forastiere T. Leong E. Rowinsky et al. Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: eastern Cooperative Oncology Group Study E1393 J Clin Oncol 19 2001 1088-1095
10. C. Jacobs F. Meyers C. Hendrickson M. Kohler S. Carter A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study Cancer 52 1983 1563-1569
11. Liverpool Head and Neck Oncology Group A phase III randomized trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous cell carcinoma of the head and neck Br J Cancer 61 1990 311-315
12. C. Jacobs G. Lyman E. Velez-Garcia et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 1992 257-263
13. B. Bendahamane P. Bontemps H. Bourgeois et al. Final results of phase II study of patients with metastatic or recurrent squamous cell carcinoma of the head and neck treated with docetaxel and 5-fluorouracil Proc Am Soc Clin Oncol 19 2000 1656a
14. B. Murphy Y. Li D. Cella et al. Phase III study comparing cisplatin and 5-fluorouracil versus cisplatin and paclitaxel in metastatic/recurrent head and neck cancer Proc Am Soc Clin Oncol 20 2001 894a
15. B.A. Burtness Y. Li W. Flood et al. Phase III trial comparing cisplatin and placebo to cisplatin and anti-epidermal growth factor antibody C225 in patients with metastatic/recurrent head and neck cancer Proc Am Soc Clin Oncol 21 2002 901a
16. M. Rooney J. Kish J. Jacobs et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin Cancer 55 1985 1123-1128
17. A. Forastiere W. Koch A. Trotti D. Sidransky Head and neck cancer N Engl J Med 345 2001 1890-1900
18. K.K. Ang G.L. Jiang Y. Feng L.C. Stephens S.L. Tucker R.E. Price Extent and kinetics of recovery of occult spinal cord injury Int J Radiat Oncol Biol Phys 50 2001 1013-1020
19. C. Nieder L. Milas K.K. Ang Tissue tolerance to reirradiation Semin Radiat Oncol 10 2000 200-209
20. A. Lee W. Foo S. Law et al. Re-irradiation for recurrent nasopharyngeal carcinoma: Factors affecting the therapeutic ratio and ways for improvement Int J Radiat Oncol Biol Phys 38 1997 43-52
21. B. Emami M. Bignardi G.J. Spector V.R. Devineni M.A. Hederman Reirradiation of recurrent head and neck cancers Laryngoscope 97 1987 85-88
22. C.C. Wang J. McIntyre Re-irradiation of laryngeal carcinoma - techniques and results Int J Radiat Oncol Biol Phys 26 1993 783-785
23. J. Pomp P.C. Levendag W.L. van Putten Reirradiation of recurrent tumors in the head and neck Am J Clin Oncol 11 1988 543-549
24. B. Weppelmann R.H. Wheeler G.E. Peters et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and re-irradiation Int J Radiat Oncol Biol Phys 22 1992 1051-1056
25. D. Gandia P. Wibault T. Guillot et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer Head Neck 15 1993 8-15
26. K.R. Stevens Jr. A. Britsch W.T. Moss High-dose reirradiation of head and neck cancer with curative intent Int J Radiat Oncol Biol Phys 29 1994 687-698
27. M. Benchalal J.M. Bachaud P. Francois et al. Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study Radiother Oncol 36 1995 203-210
28. D.J. Haraf R.R. Weichselbaum E.E. Vokes Reirradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease Ann Oncol 7 1996 913-918
29. R. De Crevoisier J. Bourhis C. Domenge et al. Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 1998 3556-3562
30. 30 S.A. Spencer R.H. Wheeler G.E. Peters et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck Am J Clin Oncol 22 1999 1-5
31. D.J. Haraf K. Chung M. Stenson et al. High dose re-irradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (NHC): Results in 48 patients Proc Am Soc Clin Oncol 19 2000 413a
32. L.A. Dawson L.L. Myers C.R. Bradford et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 377-385
33. L.A. Dawson L.L. Myers C.R. Bradford et al. Laryngoscope 2001;97:85-88
34. S.A. Spencer J. Harris R.H. Wheeler et al. RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 2001 1299-1304
35. C.C. Wang Re-irradiation of recurrent nasopharyngeal carcinoma - treatment techniques and results Int J Radiat Oncol Biol Phys 13 1987 953-956
36. D. Peiffert M. Pernot L. Malissard et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: Results in 73 cases Int J Radiat Oncol Biol Phys 29 1994 681-686
37. 36 J.J. Mazeron D. Langlois D. Glaubiger et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases Int J Radiat Oncol Biol Phys 13 1987 957-962
38. C.E. Hall R. Harris R. A'Hern et al. Le Fort I osteotomy and low-dose rate Ir192 brachytherapy for treatment of recurrent nasopharyngeal tumours Radiother Oncol 66 2003 41-48
39. K.K. Fu T. Pajak A. Trotti et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7-16
40. N.R. Datta A.D. Choudhry S. Gupta Twice a day versus once a day radiation therapy in head and neck cancer Int J Radiat Oncol Biol Phys 17 1989 132
41. J.C. Horiot R. Le-Fur T. Nguyen et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231-241
42. F. Sanchiz A. Milla J. Torner et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer Int J Radiat Oncol Biol Phys 19 1990 1347-1350
43. L.H. Pinto P.C. Canary C.M. Araujo et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 21 1991 557-562
44. K.K. Ang A. Trotti A.S. Garden et al. Importance of overall time factor in postoperative radiotherapy In: J.P. Shah J.T. Johnson eds. 4th International Conference on head and neck cancer 1996 The Society of Head and Neck Surgeons and American Society of Head and Neck Surgery Toronto, Canada 231-235
45. H.K. Awwad Y. Khafagy M. Barsoum et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumour proliferation Radiother Oncol 25 1992 261-266
46. J.C. Horiot P. Bontemps W. van den Bogaert et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111-121
47. C.R. Johnson R.K. Schmidt-Ullrich D.E. Wazer Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck Cancer 69 1992 2749-2754
48. J. Overgaard H. Sand Hansen M. Overgaard et al. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck: A randomized multicenter study of 5 versus 6 fractions per week - report from the DAHANCA 7 trial Int J Radiat Oncol Phys 39 1997 188
49. J.P. Pignon J. Bourhis C. Domenge et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of Chemotherapy on Head and Neck Cancer Lancet 355 2000 949-955
50. M. Merlano M. Benasso R. Corvo et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 1996 583-589
51. T.G. Wendt G.G. Grabenbauer C.M. Rodel et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study J Clin Oncol 16 1998 1318-1324
52. M. Al-Sarraf M. LeBlanc P.G. Giri et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310-1317
53. D.M. Brizel M.E. Albers S.R. Fisher et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798-1804
54. G. Calais M. Alfonsi E. Bardet et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081-2086
55. D.J. Adelstein Y. Li G.L. Adams et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92-98
56. J.S. Cooper T.F. Pajak A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937-1944
57. J. Bernier C. Domenge M. Ozsahin et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced H&N cancer N Engl J Med 350 2004 1945-1952
58. S.J. Chimura E.E. Vokes M. Garofalo et al. Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 57 2003 S409-S410
59. C. Nutting D.P. Dearnaley S. Webb Intensity modulated radiation therapy: a clinical review Br J Radiol 73 2000 459-469
60. Y.J. Chen J.V. Kuo N.S. Ramsinghani M.S. Al-Ghazi Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer Med Dosim 27 2002 171-176
61. T.X. Lu W.Y. Mai B.S. Teh et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 58 2004 682-687
62. J. Kao M.C. Garofalo M.T. Milano et al. Reirradiation of recurrent and second primary head and neck malignancies: A comprehensive review Cancer Treat Rev 29 2003 21-30
63. T. Rampling H. King K.L. Mais et al. Quality of life measurement in the head and neck cancer radiotherapy clinic: Is it feasible and worthwhile? Clin Oncol 15 2003 205-210